Form 4: Director Sells NVNO Shares Under 10b5-1 Plan

enVVeno Medical Corp Director Francis Duhay sold 140 shares of common stock for $11.5224 per share under a pre-arranged 10b5-1 trading plan.

Summary

• Francis Duhay, a Director of enVVeno Medical Corp (NVNO), reported a sale of common stock.
• The transaction involved the disposition of 140 shares of common stock.
• The shares were sold on March 12, 2026, at a weighted-average price of $11.5224 per share.
• The sale was executed pursuant to a Rule 10b5-1 trading plan adopted by Mr. Duhay in June 2025.
• Following this transaction, Mr. Duhay beneficially owns 2,502 shares of enVVeno Medical Corp common stock directly.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event. A routine insider sale under a pre-arranged 10b5-1 plan typically does not signal a change in company fundamentals or management's outlook.

Industry Context

StockSavvy.ai notes that insider sales executed under a Rule 10b5-1 trading plan are pre-scheduled and often reflect personal financial planning rather than a change in the insider's view of the company's future prospects. Such transactions are common among executives and directors for liquidity management.

Stakeholder Impact

• Shareholders: Minimal impact as this is a small, pre-planned insider sale, not indicative of a shift in company performance or outlook.

Key Dates

Keywords

enVVeno Medical Corp, NVNO, Form 4, Insider Transaction, Stock Sale, Francis Duhay, 10b5-1 Plan